Young adults 11 to 25 years old who have been diagnosed with Crohn’s disease or ulcerative colitis who are taking a stable maintenance medication may be eligible to participate.
This study includes 4 study visits over a 5 month period and a telephone contact prior to each study visit.
Participants will be randomized (selection random like flipping a coin) to receive 1 of 3 doses of a prebiotic or a placebo (looks like the supplement but does not contain the prebiotic). The study supplement will be in a single dose packet, and you will take the study supplement once per day in the morning with water.
Throughout the study, we will review your electronic medical record to obtain any relevant information such as medical history, medication changes, etc.
Here are some of the other things that will happen in this study:
You will:
We will ask you to record each daily dose of the study supplement.
You will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.
You may not have a direct medical benefit. If you receive the prebiotic, it may promote healthy bacteria in your intestine. However, being in this study may not help you right now.
When we complete this study, we hope that we will know more about IBD and how to best treat it. This may help other children and adults with IRB in the future.
You will receive up to $280 for 4 study visits.
Ramona Bezold
513-636-1412
ramona.bezold@cchmc.org
Gastroenterology, Hepatology & Nutrition
Cincinnati Children’s Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039